|
|
Blood, 15 June 2008, Vol. 111, No. 12, pp. 5537-5543.
Prepublished online as a Blood First Edition Paper on April 3, 2008; DOI 10.1182/blood-2007-09-115022.
 Previous Article | Next Article 
Submitted September 27, 2007
Accepted March 12, 2008
Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors
Grant D. Trobridge, Brian C. Beard, Christina Gooch, Martin Wohlfahrt, Philip Olsen, James Fletcher, Punam Malik, and Hans-Peter Kiem*
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, Uganda
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seatttle, WA, United States
Department of Medicine, University of Washington School of Medicine, Seattle, WA, United States
Department of Experimental Hematology and Division of Hematology Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
* Corresponding author; email: hkiem{at}fhcrc.org.
Lentiviral vectors are attractive for hematopoietic stem cell (HSC) gene therapy because they do not require mitosis for nuclear entry, they efficiently transduce hematopoietic repopulating cells, and self-inactivating (SIN) designs can be produced at high titer. Experiments to evaluate HIV-derived lentiviral vectors in nonhuman primates prior to clinical trials have been hampered by low transduction frequencies due in part to host restriction by TRIM5 . We have established conditions for efficient transduction of pigtailed macaque (Macaca nemestrina) long term repopulating cells using VSV-G pseudotyped HIV-based lentiviral vectors. Stable, long-term, high-level gene marking was observed in three macaques using relatively low MOIs (5-10) in a 48 hour ex vivo transduction protocol. All animals studied had rapid neutrophil engraftment with a median of 10.3 days to a count greater than 500/µl. Expression was detected in all lineages, with long-term marking levels in granulocytes at approximately 20-30%, and in lymphocytes at approximately 12-23%. All animals had highly polyclonal engraftment as determined by analysis of vector integration sites. These data suggest that lentiviral vectors should be highly effective for HSC gene therapy, particularly for diseases in which maintaining the engraftment potential of stem cells by using short term ex vivo transduction protocols is critical.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Uchida, K. N. Washington, J. Hayakawa, M. M. Hsieh, A. C. Bonifacino, A. E. Krouse, M. E. Metzger, R. E. Donahue, and J. F. Tisdale
Development of a Human Immunodeficiency Virus Type 1-Based Lentiviral Vector That Allows Efficient Transduction of both Human and Rhesus Blood Cells
J. Virol.,
October 1, 2009;
83(19):
9854 - 9862.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Beard, R. Sud, K. A. Keyser, C. Ironside, T. Neff, S. Gerull, G. D. Trobridge, and H.-P. Kiem
Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients
Blood,
May 21, 2009;
113(21):
5094 - 5103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
